Radiotherapy Market 2018: Opportunities, Sales Revenue, Emerging Trends, Competitive Landscape, Top Key Players Study by Forecast to 2025

A SWOT analysis of the new projects being undertaken in the global radiotherapy industry identifies, studies, and analyzes the strengths, weaknesses, opportunities, and threats of the upcoming projects, together with an evaluation of the investment feasibility, investment returns, and development trends.

Logo

Pune, India -- (SBWire) -- 07/13/2018 --Radiotherapy also known as radiation therapy is the treatment of cancer which uses high energy radiation to kill cancer tissues in the body. This therapy stops cancer cells from multiplying in the body. According to national center for biotechnology information, more than 14 million new cases of cancer are diagnosed each year and radiation therapy has a potential to improve the rates of cure for about 3.5 million people along with providing relief to additional 3.5 million people.

Global Radiotherapy Market is expected to reach USD 9.3 billion by 2024 from USD 5.2 billion in 2016, at a CAGR of 7.5% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Click Here for Free Sample Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-radiotherapy-market

According to the research published in the journal of medical imaging and radiation oncology, the most effective treatment for prostate cancer is external-beam radiation therapy. Men with prostate cancer who are treated with external-beam radiation therapy have cure rate of 95.5% for intermediate risk prostate cancer and 91.3% for high risk prostate cancer. It was found that the patient treated with modern external-beam radiation therapy has 98.8% free survival rate for 5 years.

A study was conducted on 715 women who were suffering from stage 1uterine cancer by Texas oncology, to observe the difference in treatment with surgery alone and treatment with surgery followed by adjuvant external beam radiation therapy. It was found that the cancer recurrence rate was 4.0% and the survival rate was 81.0% in the patients treated with surgery followed by adjuvant external beam radiation therapy and the cancer recurrence rate was 14.0% and the survival rate was 85.0% in the patients who were treated with surgery alone. The survival rate was higher in treatment by surgery alone because the radiation had various side effects on women.

In Florida a study was conducted on 396 women who were suffering from stage 1 uterine cancer treated with hysterectomy, lymph node dissection and brachytherapy. From the study it was observed that the 5 years survival rate was 100.0% for cancer confined to the inner layer of cells of the uterus, 97.0% for the patients with cancer that invades less than one half of the muscle wall of the uterus and 93.0% for the patients with cancer that invades more than one half of the muscle wall of the uterus .

Have Any Query? Inquire here @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-radiotherapy-market

TABLE OF CONTENTS GLOBAL RADIOTHERAPY MARKET

1. INTRODUCTION

1.1. OVERVIEW OF GLOBAL RADIOTHERAPY MARKET
1.1.1. CURRENCY AND PRICING
1.1.2. LIMITATION
1.1.3. MARKETS COVERED

2. MARKET SEGMENTATION

3. MARKET OVERVIEW

3.1. DRIVERS

3.1.1. GROWING PREVALENCE OF CANCER
3.1.2. RISING AGEING POPULATION
3.1.3. UNHEALTHY LIFESTYLE
3.1.4. MERGERS AND ACQUISITIONS TO EXPAND BUSINESS

3.2. RESTRAINTS

3.2.1. REGULATORY SCENARIO
3.2.2. HIGH COST OF RADIOTHERAPY

3.3. OPPORTUNITIES

3.3.1. GROWING MEDICAL TOURISM IN ASIA
3.3.2. EMERGING MARKET

3.4. CHALLENGES

3.4.1. SIDE-EFFECTS OF RADIOTHERAPY
3.4.2. REQUIREMENT OF TRAINED STAFF

4. EXECUTIVE SUMMARY

5. PREMIUM INSIGHTS

6. GLOBAL RADIOTHERAPY MARKET, BY THERAPY TYPE

6.1. OVERVIEW
6.2. BEAM RADIOTHERAPY, BY THERAPY TYPE
6.3. BRACHYTHERAPY, BY THERAPY TYPE

7. GLOBAL RADIOTHERAPY MARKET, BY PRODUCT TYPE

7.1. OVERVIEW
7.2. GLOBAL EXTERNAL BEAM RADIOTHERAPY MARKET, BY PRODUCT TYPE
7.3. GLOBAL INTERNAL BEAM RADIOTHERAPY MARKET, BY PRODUCT TYPE
7.4. GLOBAL RADIOTHERAPY SOFTWARES MARKET, BY PRODUCT TYPE

8. GLOBAL RADIOTHERAPY MARKET, BY INDICATION

8.1. OVERVIEW

9. GLOBAL RADIOTHERAPY MARKET, BY GEOGRAPHY

9.1. OVERVIEW

9.2. NORTH AMERICA RADIOTHERAPY MARKET SNAPSHOT: 2016

9.2.1. U.S. RADIOTHERAPY MARKET
9.2.2. CANADA RADIOTHERAPY MARKET
9.2.3. MEXICO RADIOTHERAPY MARKET

9.3. EUROPE RADIOTHERAPY MARKET

9.3.1. GERMANY RADIOTHERAPY MARKET
9.3.2. FRANCE RADIOTHERAPY MARKET
9.3.3. U.K. RADIOTHERAPY MARKET
9.3.4. SWITZERLAND RADIOTHERAPY MARKET
9.3.5. ITALY RADIOTHERAPY MARKET
9.3.6. RUSSIA RADIOTHERAPY MARKET
9.3.7. NETHERLANDS RADIOTHERAPY MARKET
9.3.8. SPAIN RADIOTHERAPY MARKET
9.3.9. BELGIUM RADIOTHERAPY MARKET
9.3.10. TURKEY RADIOTHERAPY MARKET

9.4. APAC RADIOTHERAPY MARKET SNAPSHOT: 2016

9.4.1. JAPAN RADIOTHERAPY MARKET
9.4.2. CHINA RADIOTHERAPY MARKET
9.4.3. INDIA RADIOTHERAPY MARKET
9.4.4. SOUTH KOREA RADIOTHERAPY MARKET
9.4.5. AUSTRALIA RADIOTHERAPY MARKET
9.4.6. THAILAND RADIOTHERAPY MARKET
9.4.7. MALAYSIA RADIOTHERAPY MARKET
9.4.8. INDONESIA RADIOTHERAPY MARKET
9.4.9. SINGAPORERADIOTHERAPY MARKET
9.4.10. PHILIPPINES RADIOTHERAPY MARKET

9.5. SOUTH AMERICA RADIOTHERAPY MARKET SNAPSHOT: 2016

9.5.1. BRAZIL RADIOTHERAPY MARKET

9.6. MEA RADIOTHERAPY MARKET SNAPSHOT: 2016

9.6.1. SAUDI ARABIA RADIOTHERAPY MARKET

10. GLOBAL RADIOTHERAPY MARKET, COMPANY SHARE

10.1. COMPANY SHARE ANALYSIS: GLOBAL
10.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
10.3. COMPANY SHARE ANALYSIS: EUROPE
10.4. COMPANY SHARE ANALYSIS: ASIA PACIFIC

11. COMPANY PROFILES

11.1. VARIAN MEDICAL SYSTEMS, INC.

11.2. ELEKTA AB

11.3. NANOBIOTIX

11.4. ACCURAY, INC.

11.5. BRAINLAB AG

11.6. ION BEAM APPLICATIONS SA

12. RELATED REPORTS

Any specific requirements are you looking for? Ask to your Industry Experts: http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-radiotherapy-market

Related Report

Europe Radiotherapy Market – Industry Trends and Forecast to 2024

Europe Radiotherapy Market, By Therapy (Beam Radiotherapy (IGRT, IMRT, VMAT, Tomotherapy, 3D CRT, Proton Beam, Stereotactic), Brachytherapy (LDR, HDR), Systemic Radiotherapy), By Product Type (Cyberknife, Gammaknife, Linac, Proton Beam, Systemic Radiotherapy, Seeds, Afterloaders), By Indication (Prostate & Breast Cancer)), By Country (Germany, France, U.K., Spain, Italy, Russia, Netherlands, Turkey, Belgium, Switzerland, Rest of Europe) – Industry Trends and Forecast to 2024

http://databridgemarketresearch.com/reports/europe-radiotherapy-market/

About Data Bridge Market Research
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

Media Relations Contact

Sopan Gedam
Manager
Data Bridge Market Research
1-888-387-2818
https://databridgemarketresearch.com/reports/global-radiotherapy-market/

View this press release online at: http://rwire.com/1011296